The Novo Nordisk A/S (NVO) ROIC is 35.5%, compared to the industry median of ((44.8%)) and the 5-year historical average of 36.4%.
The Novo Nordisk A/S (NVO) ROIC minus WACC is 28.0%, compared to the industry median of ((37.1%)) and the 5-year historical average of 30.5%.
The Novo Nordisk A/S (NVO) ROE is 76.5%, compared to the industry median of ((37.3%)) and the 5-year historical average of 74.8%.
The Novo Nordisk A/S (NVO) ROCE is 46.8%, compared to the industry median of ((40.3%)) and the 5-year historical average of 54.5%.